Cronos Group Inc
Why Canopy Growth’s BC Cannabis Cultivation License Is a Big Deal
On February 20, 2018, Canopy Growth (WEED) announced that it had received a cultivation license for one of its two sites at Aldergrove, British Columbia, under its BC Tweed Joint Venture.
How Canopy Growth Is Preparing for Legalized Cannabis
During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17.
How Analysts’ Estimates for Cannabis Companies Have Evolved
Earlier, we were left with the question of whether the valuations of cannabis stocks had been stretched. To answer that question, we’ll have to look at what was priced in to their valuation multiples.
What Cronos Group’s Listing on the NASDAQ Global Market Means
With the elevation of its listing to the NASDAQ Global Market from the NASDAQ International Designation program, Cronos Group’s (PRMCF) management believes…
Why Cannabis Stock Cronos Group Surged 11% Yesterday
On February 26, cannabis company (HMMJ) Cronos Group (MJN)(PRMCF) surged almost 10.8%.
A Review of the Biggest Losers in the Cannabis Sector Last Week
With the increased perception of market risk, it’s natural that cannabis-related stocks also experienced a sell-off last week. Let’s look at this in more detail.
Aurora Cannabis’s Reach and the CanniMed Acquisition
In our series Must-Knows before Investing in the Marijuana Industry, we saw how, globally, the acceptance of marijuana has evolved, with more countries either legalizing cannabis access at a federal level or exploring the possibility of legalizing cannabis.
How Wall Street Is Taking an Interest in the Marijuana Industry
Marijuana is still classified as a Schedule 1 drug in the United States and is illicit under federal law. This has created several issues for businesses.